Click on this amazing episode. UEG J podcast - better than ever.

🧪 PredictSURE #IBD Assay may guide earlier, risk-stratified therapy in #UlcerativeColitis 🛡️High-risk UC patients had more/earlier escalations, while steroids at baseline impaired accuracy 📖 #OpenAccess 👉 https://t.co/Eu8hxFLeUK @my_ueg​ @albrechtneesse​ @drkeithsiau

📢 New study alert! Early anti-TNF 💊 may not suit everyone with #IBD. 🟢 For CD, early start = ✅ fewer surgeries & better outcomes. 🔴 For UC, early use = 🔺 more hospital & ED visits. 🧵🪡 timing is crucial—especially for UC! ⬇️⬇️⬇️ https://t.co/CKiEu0KjwY @my_ueg

🚨Over 50% of anoperineal fistulas in #Crohns are refractory to standard Tx. New data shows combo therapy (infliximab + ustekinumab) yields: ✔️ 48.5% clinical remission ✔️ 28.6% radiological remission 🧠 97% positive Tx perception ⏳ to rethink 🤔 Tx. https://t.co/0jywa1iccy

It is here! Better than ever!

Happy to share our Perspective "Microbiome for clinicians" https://t.co/m2u0HdIfPm, just out in @CellCellPress. A piece written by #microbiomeclinicians (@Siew_C_Ng @GiovanniCammar9 @h_sokol @EranElinav @Elinav_Lab @WeersmaLab & many others) for #microbiome clinicians.

🎙️ Guess who’s back? The UEGJ Podcast returns in a 🔥 🆕 format hosted by: ⭐️ @MohsenSubhani ⭐️@MMEstevinho Each episode = a rapid-fire rundown of 5 must-read GI articles Quick, sharp, and tailored 🧵 to YOUR clinical practice. 🎉 Stay tuned. Your 🧠 will thank you. @my_ueg

🔬Gut #Microbiota plays a key role in the development of intestinal fibrosis #CreepingFat in #Crohn’s disease. Microbial species and their metabolites drive inflammation, fibroblast activation, ECM buildup & mesenteric fat changes 📖 #OpenAccess 👉 https://t.co/bkGqKpLMrw

Inspiring talk by @gianluca1aniro on FMT and microbiome-based therapies at the #ESGHAMI @ESCMID educational course. The future lies in training clinicians in microbiome science and setting rational expectations and applications for microbiome-based therapies. #microbiomeclinician

Welcome to the first @ESCMID Educational Course on the Microbiome in Turin organized by #ESGHAMI and @unito! Excellent first talk by Pr. Ferrocino on how microbial strains can be transmitted all along the Food chain! @EdKuijper2

Recent data in @UEGJournal shows the impact of rifaximin on hepatic encephalopathy episodes, therefore keeping patients out of hospital 👍 📸: https://t.co/zvANjTm3qI

@my_ueg 🧪 With PERT: ✅ Fewer bowel movements ✅ Better stool consistency ✅ Higher remission ✅ Improved QoL, anxiety & depression ✅ Fewer dropouts 💡A promising, targeted approach for tackling EEN intolerance in Crohn’s disease — and improving treatment success #Crohns

Let's join us Hall 15 to know everything about probiotics in Infectious Diseases !! #ESGHAMI @EdKuijper2 @ESCMID

Sometimes you need a break 🏖️ STILL: @UEGJournal serves u also from the beach 🔥 50% increase of submissions in 2025 📈 Online and Altmetrics score rise, IF 5.7 👍 Infographics + podcasts increase citations 👈waiting for your best submissions 💪we make quick first decisions

@albrechtneesse is completely right @uegjournal works for you Every day to make a difference Bring your science to @uegjournal You will be rewarded @drkeithsiau

Problems in #AI 🤖 paradise? 😿 The complexity of luminal findings reveal a major "domain gap." Current AI, trained on ⬆️quality datasets, struggles with complexity of routine practice. Future - more robustness, not only heterogeneity. @my_ueg @drkeithsiau @CarlKayMD

🚨 Patients with chronic kidney disease (CKD) are at a ⬆️ risk of bleeding 🩸 after polypectomy 🔪, 📊 the risk is associated to all CKD stages. 🏥 Close 👀 for at least 1 month post-polypectomy is crucial. 🔗 https://t.co/gJVKUrH6p8 @my_ueg @ESGE_news @drkeithsiau

It's #CRC awareness month! 🔍 📢🔥Defining Optimal #Surveillance Intervals⏳ Following Post-#Colorectal #Endoscopic #Submucosal #Dissection 🔪💩 📄Editorial by @ThirdspaceEndo @DarylRamai @LumirKunovsky 👉 Dive in: https://t.co/ljcVIusmCu 🟢 @my_ueg @OncoAlert @EuropeanCancer

🔬 A Delphi panel study identified a consensus on non-invasive tests for diagnosing & monitoring alpha‐1 antitrypsin deficiency-associated liver disease 📊 VCTE is the preferred tool for initial assessment 📖 #OpenAccess 👉 https://t.co/rJKxhgi93S @my_ueg #LiverTwitter

🧠💥 Multiple concomitant precipitating factors of hepatic encephalopathy are linked to poor prognosis in cirrhotic patients in the ICU. 🔬Why it matters? Early screening & management can improve outcomes! 📖 #OpenAccess at 👉 https://t.co/YQ4KEKPEM8 @my_ueg #LiverTwitter